First Time Loading...

Valeo Pharma Inc
TSX:VPH

Watchlist Manager
Valeo Pharma Inc Logo
Valeo Pharma Inc
TSX:VPH
Watchlist
Price: 0.105 CAD -8.7%
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

VPH Price Targets Summary
Valeo Pharma Inc

Wall Street analysts forecast VPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VPH is 0.51 CAD with a low forecast of 0.404 CAD and a high forecast of 0.63 CAD.

VPH Lowest Forecast
Wall Street Target
0.404 CAD
285% Upside
VPH Average Forecast
Wall Street Target
0.51 CAD
386% Upside
VPH Highest Forecast
Wall Street Target
0.63 CAD
500% Upside
Lowest
Price Target
0.404 CAD
285% Upside
Average
Price Target
0.51 CAD
386% Upside
Highest
Price Target
0.63 CAD
500% Upside
Valeo Pharma Inc Competitors:
Price Targets
ELAN
Elanco Animal Health Inc
33% Upside
BOI
Boiron SA
26% Upside
M
MANKIND
Mankind Pharma Ltd
9% Downside
PAHC
Phibro Animal Health Corp
35% Downside
ELAN
Elanco Animal Health Inc
33% Upside
BOI
Boiron SA
26% Upside
M
MANKIND
Mankind Pharma Ltd
9% Downside
PAHC
Phibro Animal Health Corp
35% Downside
PBP
Probiotec Ltd
8% Upside
L
503
Lansen Pharmaceutical Holdings Ltd
78% Downside

Revenue
Forecast

Revenue Estimate
Valeo Pharma Inc

For the last 6 years the compound annual growth rate for Valeo Pharma Inc's revenue is 87%. The projected CAGR for the next 2 years is 19%.

87%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Valeo Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
19%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Valeo Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

See Also

Summary
VPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
VPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VPH stock valuation using valuation multiples.
Wall Street Estimates
VPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VPH's stock price target?
Price Target
0.51 CAD

According to Wall Street analysts, the average 1-year price target for VPH is 0.51 CAD with a low forecast of 0.404 CAD and a high forecast of 0.63 CAD.

What is Valeo Pharma Inc's Revenue forecast?
Projected CAGR
19%

For the last 6 years the compound annual growth rate for Valeo Pharma Inc's revenue is 87%. The projected CAGR for the next 2 years is 19%.

ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.